How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning:: the case of lymph node staging in melanoma

被引:37
作者
Mijnhout, GS
Hoekstra, OS
van Lingen, A
van Diest, PJ
Adèr, HJ
Lammertsma, AA
Pijpers, R
Meijer, S
Teule, GJJ
机构
[1] VU Univ Med Ctr, Dept Nucl Med, NL-1007 MB Amsterdam, Netherlands
[2] VU Univ Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] VU Univ Med Ctr, Dept Surg Oncol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1136/jcp.56.4.283
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: In primary cutaneous melanoma, the sentinel node (SN) biopsy is an accurate method for the staging of the lymph nodes. Positron emission tomography (PET) has been suggested as a useful alternative. However, the sensitivity of PET may be too low to detect SN metastases, which are often small. Aim: To predict the value of PET for initial lymph node staging in melanoma based on morphometric analysis of SN metastatic load, without exposing patients to PET. Material and methods: In 59 SN positive patients with melanoma, the sizes of tumour deposits in the SNs and subsequent dissection specimens were measured by morphometry and correlated with the detection limits of current and future PET scanners. Results: The median tumour volume within the basin was 0.15 mm(3) (range, 0.0001-118.86). Seventy per cent of these deposits were smaller than 1 mm(3). State of the art PET scanners that have a resolution of about 5 mm would detect only 15-49% of positive basins. Logistic regression analysis revealed no pretest indicators identifying patients expected to have a positive PET. However, the SN tumour load was a significant and single predictor of the presence of PET detectable residual tumour. Conclusion: Morphometric analysis of metastatic load predicts that PET scanning is unable to detect most metastatic deposits in sentinel lymph nodes of patients with melanoma because the metastases are often small. Therefore, the SN biopsy remains the preferred method for initial regional staging.
引用
收藏
页码:283 / 286
页数:4
相关论文
共 35 条
[1]   Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma [J].
Acland, KM ;
Healy, C ;
Calonje, E ;
O'Doherty, M ;
Nunan, T ;
Page, C ;
Higgins, E ;
Russell-Jones, R .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2674-2678
[2]   Are locoregional cutaneous metastases in melanoma predictable? [J].
Borgstein, PJ ;
Meijer, S ;
van Diest, PJ .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (03) :315-321
[3]  
Crippa F, 2000, J NUCL MED, V41, P1491
[4]   Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up [J].
Cserni, G .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (12) :922-924
[5]  
Eggermont AMM, 1998, EUR J CANCER, V34, pS22
[6]  
Giard R W, 1999, Ned Tijdschr Geneeskd, V143, P1766
[7]   Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management [J].
Greco, M ;
Crippa, F ;
Agresti, R ;
Seregni, E ;
Gerali, A ;
Giovanazzi, R ;
Micheli, A ;
Asero, S ;
Ferraris, C ;
Gennaro, M ;
Bombardieri, E ;
Cascinelli, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) :630-635
[8]  
GRITTERS LS, 1993, J NUCL MED, V34, P1420
[9]   PET in oncology: Will it replace the other modalities? [J].
Hoh, CK ;
Schiepers, C ;
Seltzer, MA ;
Gambhir, SS ;
Silverman, DHS ;
Czernin, J ;
Maddahi, J ;
Phelps, ME .
SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (02) :94-106
[10]   Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma [J].
Macfarlane, DJ ;
Sondak, V ;
Johnson, T ;
Wahl, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1770-1776